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Scope 
 
Although therapeutic ultrasound has been used for over 50 years in physiotherapy, 
its use in the clinical environment has changed significantly over this period, and 
whereas in the past, its use was primarily for its thermal effect, it is now more widely 
employed for its ‘non thermal’ effects, especially in relation to tissue repair and 
wound healing.  
 
There is a substantial volume of published evidence relating to the effects and use of 
ultrasound as a therapeutic modality, and the overall aim of this paper is to review 
the current use of ultrasound in the realm of physiotherapy and associated practice, 
providing an overview of key issues. Whilst considering the evidence and providing 
key reference material, it does not purport to be a systematic review of the literature. 
  
Historical use and recent developments 
 
Ultrasound is almost certainly the most widely used of the electrophysical agents in 
current clinical practice. In addition to its widespread use by physiotherapists  [1-3], it 
is also commonly used by numerous therapists from other professional groups (e.g. 
osteopaths, chiropractors, sports therapists). The results of a recent national survey 
of physiotherapists carried out in Australia [4] indicates that therapeutic ultrasound 
remains the most popular modality in use. 
 
The results of a survey carried out in Britain in 1985 [2] showed that 20% of all 
physiotherapy treatments in NHS departments and 54% of all private treatments 
involved therapeutic ultrasound and the widely cited survey by Pope et al [1] 
identified ultrasound as the most frequently employed modality (94%) and 64% of 
respondents reported that they used the modality more than once a day.  
 
In the 1985 survey, it was shown that there were large variations in the use of 
ultrasound including a range of intensities from 0.1 – 3.0 W/cm2 giving a variation 
factor of 30 from the lowest to the highest applied intensity. The current application 
of ultrasound for fracture healing at even lower doses (typically 0.03 W/cm2) would 
take that to a factor of 100. This is a very substantial variation on just one factor that 
affects the output of the machine, and it is not surprising therefore that some 
research evidence is supportive of the modality whilst other publications are clearly 
not. Given that the effects of ‘electrotherapy’ interventions have a dose dependency 
[5], this wide variation in applied power would be expected to generate a range of 
effects including more and less effective therapeutic outcomes. Further identification 
of the critical machine and dose parameters is clearly needed and is being 
undertaken within this research group. 
 
Physics Related Issues 
The physics of therapeutic ultrasound are outwith the remit of this paper, but there 
are two essential issues that have a direct influence of practice and will therefore be 
identified in that context. 
 
Coupling Media 
 
Ultrasound will be reflected at the metal/air interface found at the treatment head, it 
is necessary to provide a medium through which the ultrasound can freely pass in 
order to reach the patients tissues. This medium is most commonly referred to as a 
coupling medium, and several different types are used in practice. Given that the job 
of the coupling medium is to allow transmission of the ultrasound, a coupling medium 
that absorbs, changes or disturbs the ultrasound energy is not performing in an ideal 
way.  
 
The coupling media used in this context include water, various oils, creams and gels. 
Ideally, the coupling medium should be sufficiently fluid to fill all available spaces, 
relatively viscous so that it stays in place, have an impedance appropriate to the 
media it connects, and should allow transmission of ultrasound energy with minimal 
absorption, attenuation or disturbance. For extensive discussions regarding coupling 
media, see [6-10]. Water and gel based media are clearly preferable to oil and cream 
based media. A recent detailed study considering the effect of different coupling gels 
on ultrasound transmission did demonstrate that there were differences in 
transmission characteristics and absorption levels of commonly employed ultrasound 
gels [9] but that there was no clinically significant difference between them. Most of 
the commonly employed gels only varied in their absorption characteristics by 
approximately 3% compared with water, and given the inaccuracy of clinical machine 
calibration [11], this is an  insignificant variability. The addition of drug based material 
to the gel (for the purpose of phonophoresis) is not strongly supported by the 
literature, and the preliminary results from ongoing work in this unit (Todd and 
Watson) would suggest that the inclusion of pharmaceutical agents in the ultrasound 
gel appears to significantly reduce ultrasound transmission to the tissues, and 
therefore reduces the efficacy of the ultrasound component of the treatment. 
Whether this is outweighed by the clinical benefits of enhanced drug delivery 
remains to be established. 
 
In an extension to this work, the capacity for various wound dressing materials to 
transmit ultrasound has been investigated. If it can be argued that of ultrasound 
energy can be effectively passed through a wound dressing without significant 
absorption, there is a potential value for not having to disturb the dressing in order to 
apply this modality which has an established role in chronic wound management [12-
15]. Furthermore, US scanning of the wound bed and environment without having to 
remove the dressing may be clinically advantageous, especially given that the 
removal of wound dressings is considered to result in inhibited repair for several 
hours on each occasion [16]. 
 A total of 48 different wound dressings were evaluated, and there was a very wide 
variation in their transmission characteristics, ranging from excellent to zero [17]. The 
dressing included alginates, foams, honey-impregnated dressings, hydrocolloids, 
hydrogel sheets, low-adherence dressings, vapour-permeable films and odour-
absorbent dressings. In practice multiple dressings may be applied to a wound, for 
example an alginate held in place with a vapour permeable film. If ultrasound were to 
be applied through these dressings, a layer of standard couplant gel might be 
applied. Therefore additional tests were carried out on combination of 2 typical 
dressings plus couplant gel to see if the overall transmissivity was significantly 
different from what would be expected by combining the data gathered separately for 
each component. Some dressings were found to behave in an unstable fashion 
(demonstrating visible changes in the structure of the dressing material) when using 
a continuous mode of ultrasound and these were further tested with the energy 
applied in a pulsed mode. 
 
The results demonstrate that many of the dressings tested are good transmitters of 
ultrasound which suggests that there may be scope, previously unexplored, for the 
application of therapeutic US to wounds through a variety of dressings. However the 
data also demonstrate that it is not appropriate to make generalisations about 
dressing transmissivity. Each dressing has its own transmission characteristics, 
which may change with both US power and frequency. Some dressings that were 
unstable using a continuous beam demonstrated stability when the duty cycle was 
reduced to 20%, suggesting that a thermal mechanism may be involved as US 
energy absorbed by the dressing increased its temperature and may have caused its 
acoustic characteristics to change. 
 
The dressings tested vary significantly in their capacity to transmit ultrasound, and 
some demonstrate excellent US transmissivity characteristics. Even dressings of the 
same type had significantly different transmissivities. This may be of particular 
importance in the case of hydrogel dressings, since these are recommended as a 
class of dressings through which wounds may be insonated [18]. The results indicate 
that their transmissivities may vary between 80% and 100%. This means that for a 
given nominal power output by a US generator, there might be considerable disparity 
in the power reaching the wound according to the specific hydrogel dressing used. 
Differences within some other classes of dressing are much greater, with 
transmissivity varying from 100% to zero. Combination of dressings in layers showed 
results that were as would have been predicted from the individual sample data. 
Detailed analysis and ranking of the 48 dressings tested at varying frequency and 
power output are included in the original paper [17]. 
  
Absorption 
 
In order to have a therapeutic effect, absorption of the applied energy is necessary 
[19], hence the effectiveness of the modality will vary according to a tissues capacity 
to absorb the applied energy. Tissues with a higher protein content will absorb US to 
a greater extent, thus tissues with high water content and low protein content (e.g. 
blood and fat) absorb little of the US energy whilst those with a lower water content 
and a higher protein content (e.g. ligament, tendon) will absorb US far more 
efficiently. It has been suggested [19, 20] that tissues can therefore be ranked 
according to their tissue absorption (Figure 1)  
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Figure 1 : Ultrasound tissue absorption characteristics 
 
Although cartilage and bone are at the upper end of this scale, the problems 
associated with wave reflection at the tissue surface mean that a significant 
proportion of US energy striking the surface of either of these tissues is likely to be 
reflected. The best absorbing tissues in terms of clinical practice are those with high 
collagen content – ligament, tendon, fascia, joint capsule, scar tissue [3, 20-23]. 
 
The differential absorption of US energy has an important influence on clinical 
decision making. Using ultrasound to treat a lesion located in a tissue that is a poor 
absorber of the energy is less likely to be effective when compared with treating a 
tissue which is a ‘better’ absorber of the energy. For example, in a recent paper 
which evaluated the effectiveness of therapeutic ultrasound immediately following 
contusion injury in muscle [24] no significant beneficial effects were demonstrated. 
Although this could be interpreted as a negative research finding, it would be difficult 
to argue why ultrasound should have an effect following this type of injury as the 
insulted tissues will absorb a relatively small proportion of the energy and hence it is 
unlikely to have a significant effect. Trials that have evaluated the effect of the same 
modality on lesions in dense collagenous tissue have demonstrated significant 
therapeutic effects (e.g. [25, 26]).  
 
An important rider to this phenomenon is that once damaged, musculocutaneous 
tissues will repair which involves the formation of scar tissue, and hence, therapeutic 
ultrasound may be of significant clinical value in that the scar tissue becomes the 
target of the therapy. In a damaged muscle, ultrasound could therefore be expected 
to be effective once the scar tissue has become established. 
 
 
Thermal vs Non-Thermal 
 
When ultrasound travels through tissue a percentage of it is absorbed, and this leads 
to the generation of heat within that tissue. The amount of absorption depends upon 
the nature of the tissue, its degree of vascularisation, and the frequency of the 
applied ultrasound. Tissues with a high protein content absorb ultrasound more 
readily than those with a higher fat content, and also the higher the US frequency, 
the greater is the absorption rate. A biologically significant thermal effect can be 
achieved if the temperature of the tissue is raised to between 40 and 45°C for at 
least 5 minutes. Controlled heating can produce desirable effects [27], which include 
pain relief, decrease in joint stiffness and increased local blood flow. Whilst the 
therapeutic benefits of tissue heating are well established, ultrasound is relatively 
inefficient at generating sufficient thermal change in the tissues to achieve this 
therapeutic effect when applied at commonly applied clinical doses. 
 
Historically, US has been widely employed for its thermal effects, but it has been 
argued more recently that the ‘non thermal’ effects of this energy form are more 
effective [3, 19] and currently, the majority of clinical applications focus on these. 
Gallo et al [28] demonstrated that both continuous and pulsed ultrasound 
interventions generated measurable thermal changes in the tissues (muscle), but 
considering the temperature changes achieved, they would be expected to be of 
minimal therapeutic value. Garrett et al [29] compared the heating effect of a pulsed 
shortwave treatment with an ultrasound treatment, and the pulsed shortwave 
intervention was clearly more effective at achieving the required thermal change for 
therapeutic benefit. A patient treated with ultrasound in continuous mode at relatively 
high power density will feel a temperature change (mainly in the skin which is where 
thermal receptors are predominantly located), but this is not the same as achieving a 
clinically significant thermal change in deeper tissues. 
 
A recent comparative study from this research unit evaluated the efficacy of a locally 
applied thermal modality with (kilohertz) ultrasound with regards their effect on soft 
tissue extensibility [30]. Although both modalities were found to be effective in this 
regard, the ultrasound demonstrated no significant benefit over the heat treatment, 
and in fact, there was a trend for the thermal intervention producing greater benefit. 
In another ultrasound, heating and stretching study, Draper and Ricard [31] 
demonstrated that there was a clinically useful temperature rise in the tissues but 
that the return to baseline was swift, and the therapeutic window for stretching 
following US application was limited to some 3 minutes immediately after treatment. 
Although there are certainly ultrasound generated thermal changes in the tissues, it 
is important to differentiate between those produced in the skin and superficial 
tissues – where they are easily detected by the patient – and those generated at 
‘depth’ which are of more clinical importance, and are not readily identifiable by the 
recipient of the therapy. An example of the skin surface thermal changes are seen in 
Figure 2. Ultrasound was applied for 5 minutes at 1.5 W cm2 in continuous mode 
using a 3MHz application over an area of twice the treatment head. The change in 
peak temperature in the central hand zone was from 34.3 C to 37.3 C by the end of 
the application. Clearly, this is more than sufficient for the patient to report a feeling 
of warmth or heating, but that does not necessarily equate to a therapeutic heating at 
any tissue depth. 
 
  
(a) Baseline thermograph (b) Thermograph at the end of the 5 
minute treatment period 
 
Figure 2 : Thermographic images of the hand before and after ultrasound 
 
Ultrasound has historically been used primarily for its perceived thermal effects, and 
although this is a less frequently employed rationale in current clinical practice, there 
remain many therapists for whom the heating effects are considered to be the most 
important. Tissue heating is clearly of value in numerous clinical conditions, but the 
evidence does not fully support the use of ultrasound as an efficient thermal 
intervention. There are tissue heating methods available in clinical practice that are 
better at achieving the desired thermal changes and based on the available 
evidence, should be used in preference to ultrasound. 
 
There are many situations where ultrasound produces bioeffects and yet significant 
temperature change is not involved (e.g. low spatial-average temporal-average 
(SATA) intensity). It is not strictly true to talk about ‘non-thermal’ mechanisms, in that 
the delivery and absorption of energy in the tissues will result in a temperature rise. 
The term ‘non-thermal’ in this context relates to the fact that there is no apparent 
thermal accumulation in the tissues, and is sometimes now referred to as a 
‘microthermal’ effect [19, 32]. The physical mechanisms thought to be involved in 
producing these non-thermal effects include cavitation and acoustic streaming [10, 
22, 33]. 
 
There is evidence indicating that ‘non-thermal’ mechanisms play a primary role in 
producing a therapeutically significant effect and the focus of this section will relate 
to these effects in relation to soft tissue injury as it is the most commonly employed 
in physiotherapy clinical practice. 
 
 
Ultrasound in Soft Tissue Repair 
 
The process of tissue repair is a complex series of cascaded, chemically mediated 
events that lead to the production of scar tissue that constitutes an effective material 
to restore the continuity of the damaged tissue. The process is more complex than 
be described in this paper, but have been extensively reviewed elsewhere, including 
[34]. 
 
The effect of US during the repair process varies according to the primary events 
that are occurring in the tissues. Immediately following injury, during the tissue 
bleeding phase, it is generally considered to be inadvisable to use ultrasound in that 
if it has the capacity to enhance local blood flow, there would be a clinical 
disadvantage to doing so whilst tissue bleeding was occurring. Once active bleeding 
has stopped, it is appropriate to start using ultrasound as soon as is feasible. During 
the inflammatory phase, US has a stimulating effect on the mast cells, platelets, 
white cells with phagocytic roles and the macrophages [22, 35-37]. For example, the 
application of ultrasound induces the degranulation of mast cells, causing the 
release of arachidonic acid which itself is a precursor for the synthesis of 
prostaglandins and leukotreine – which act as inflammatory mediators [25, 37, 38]. 
By increasing the activity of these cells, the overall influence of therapeutic US is 
certainly pro-inflammatory rather than anti-inflammatory. The benefit of this mode of 
action is not to ‘increase’ the inflammatory response as such (though if applied with 
too greater intensity at this stage, it is a possible outcome [39], but rather to act as 
an ‘inflammatory opimiser’. The inflammatory response is essential to the effective 
repair of tissue and inhibition of these events serves to inhibit the repair phases that 
follow [34, 40-42], and the more efficiently the process can complete, the more 
effectively the tissue can progress to the next phase (proliferation). Studies which 
have tried to demonstrate the anti inflammatory effect of ultrasound have largely 
failed to do so (e.g.[43, 44], and have suggested that US is ineffective. It is effective 
at promoting the normality of the inflammatory events, and as such has a therapeutic 
value in promoting the overall repair events [19, 22]. 
 
Employed at an appropriate treatment dose, with optimal treatment parameters 
(intensity, pulsing and time), the benefit of US is to make the earliest repair phase as 
efficient as possible, and thus have a promotional effect on the whole healing 
cascade. For tissues in which there is an inflammatory reaction, but in which there is 
no ‘repair’ to be achieved, the benefit of ultrasound is to promote the normal 
resolution of the inflammatory events, and hence resolve the ‘problem’ This will of 
course be most effectively achieved in the tissues that preferentially absorb the 
energy. 
 
During the proliferative phase (scar production) US also has a stimulative effect 
(cellular up regulation), though the primary active targets are now the fibroblasts, 
endothelial cells and myofibroblasts [21, 36-38, 45-48]. These are all cells that are 
normally active during scar production and US is therefore pro-proliferative in the 
same way that it is pro-inflammatory – it does not change the normal proliferative 
phase, but maximises its efficiency – producing the required scar tissue in an optimal 
fashion. Harvey et al [49] demonstrated that low dose pulsed ultrasound increases 
protein synthesis and several research groups have demonstrated enhanced 
fibroplasia and collagen synthesis [46, 50-54]. There is currently a growing interest in 
the potential role for ultrasound therapy in relation to the angiogenic response which 
is an essential component of the proliferative phase, and future research may serve 
to identify additional therapeutic benefits which at the moment remain largely 
speculative, or based solely on laboratory based research (e.g. [55]). Transfer to the 
clinical environment has yet to be established. 
 
Scar tissue is an essential component of the repair, and for most musculoskeletal 
tissues, it is the best outcome that can be achieved. In many ways, tissue 
regeneration would be ideal, but is not available in most musculoskeletal tissues. 
Functional scar tissue may be considered to be second best – but the aim of therapy 
should be to promote the construction of the most efficient scar possible. 
 
During the remodelling phase of repair, the somewhat generic scar that is produced 
in the initial stages is refined such that it adopts functional characteristics of the 
tissue that it is repairing [34]. A scar in ligament will not ‘become’ ligament, but will 
behave more like a ligamentous tissue. This is achieved by a number of processes, 
but mainly related to the orientation of the collagen fibres in the developing scar and 
also to the change in collagen type, from predominantly Type III collagen to a more 
dominant Type I collagen [56]. The remodelling process is certainly not a short 
duration phase – research has shown that it can last for a year or more – yet it is an 
essential component of quality repair and the application of ultrasound appears to 
enhance the events normally associated with this phase. 
 
Ultrasound can influence the remodelling of the scar tissue in that it appears to be 
capable of enhancing the appropriate orientation of the newly formed collagen fibres 
and also to the collagen profile change from mainly Type III to a more dominant Type 
I construction, thus increasing tensile strength and enhancing scar mobility (e.g. 
[21]). Ultrasound applied to tissues enhances the functional capacity of the scar 
tissues [21, 53]. The role of ultrasound in this phase may also have the capacity to 
influence collagen fibre orientation as demonstrated in an elegant study by Byl et al 
[57], though their conclusions were quite reasonably some tentative. Other studies 
have demonstrated effects of ultrasound therapy on collagen behaviour in this latter 
repair stage (e.g. [26, 58-60]). 
 
The application of ultrasound during the inflammatory, proliferative and repair phases 
is not of value because it changes the normal sequence of events, but because it 
has the capacity to stimulate or enhance these normal events and thus increase the 
efficiency of the repair phases [19, 22]. It would appear that if a tissue is repairing in 
a compromised or inhibited fashion, the application of therapeutic ultrasound at an 
appropriate dose will enhance this activity. If the tissue is healing ‘normally’, the 
application will, it would appear, speed the process and thus enable the tissue to 
reach its endpoint faster than would otherwise be the case. The effective application 
of ultrasound to achieve these aims is dose dependent [5, 59] though some authors 
have challenged the reality of dose dependency in this regard (e.g. [61]). 
 
Ultrasound in Fracture Repair 
 
Low intensity pulsed ultrasound (LIPUS) has emerged as an effective therapeutic 
approach in fracture repair, for both fresh fractures and those experiencing inhibited 
repair. Whereas previously, a fracture has been considered to be a local 
contraindication to therapeutic US, the current evidence demonstrates that this is 
clearly not the case. The review of this material is covered in a separate paper and 
will not therefore be considered in detail here. It is likely that the further development 
of this therapy will influence clinical practice, though in many instances it is not 
necessary for the therapist to ‘do’ the treatment, and patient self management 
appears to be the most effective way forward in this area. Whether a standard 
therapy ultrasound machine is capable of effectively delivering the required dose is 
still not resolved. Issues relating to accurate dose (intensity) delivery and the 
relatively high Beam Nonuniformity Ratios (BNR) of current clinical devices raise 
some concern, though it has been proposed that it might be a realistic proposition 
(e.g. [62, 63]) 
 
 
Clinical Issues 
Machine Calibration 
 
Concern has been raised with regards the accuracy of clinical ultrasound machines. 
When used in research programmes, operating machine calibration is (normally) 
checked to ensure accuracy, this is less likely to be the case in practice. Even if a 
machine undergoes an annual check, this may not include a calibration check and 
Pye and Milford [11] in an evaluation of machines used in NHS practice in Scotland 
identified almost 70% of machine outputs that differed from the expected value by 
more than 30%. More accurate test and calibration procedures have been proposed, 
but at the current time, it is likely that a significant proportion of machines in use are 
not delivering what the therapists assumes (based on the output set or shown on the 
device). Weekly checks using simple balance meters may help to identify gross 
inaccuracies, but a more comprehensive and rigorous quality assurance system is 
almost certainly required. Further papers [11, 64] have identified and tried to quantify 
the risks associated with this problem and more recently [65] have reported a cost 
effective method for measuring machine output accurately. 
 
 
Potential Infection 
Infection risk is a topical issue in current practice, and the possibility of passing on 
infective micro-organisms as a result of healthcare events is a growing area of 
concern. Clearly, there is a clinical risk associated with any intervention, but these 
need to be minimised as far as possible. When using ultrasound as part of a wound 
management programme, practitioners are usually mindful of infection risk and take 
careful and adequate precautions. In ‘normal’ clinical practice, it is less common to 
find cleaning of the ultrasound treatment applicator between every treatment, though 
many departments do have comprehensive infection control policies and routinely 
clean the machines and applicators. 
 A recent study [66] investigated whether clinical ultrasound units were a potential 
vector of infection. The study aimed to determine the degree of contamination on 
therapeutic ultrasound transducer heads and ultrasound gel after routine clinical use, 
and to evaluate the efficacy of recommended infection control procedures. The study 
was conducted in Australia and microbiological cultures were obtained from 44 
transducer heads and 43 gels (machines were in use in hospitals, private practices 
and other healthcare facilities). Swabs taken from the treatment heads and the gel 
bottles were cultured and colony growth assessed. Twenty-seven per cent of 
transducer heads and 28% of gels were contaminated. Transducer heads showed 
fairly low levels of contamination across the sample, with the majority of organisms 
isolated found in normal skin and environmental flora. Gels were heavily 
contaminated with opportunistic and potentially pathogenic organisms, including 
Stenotrophomonas maltophilia, Staphylococcus aureus, Acinetobacter baumannii 
and Rhodotorula mucilaginosa. No multi-resistant organisms were identified. 
 
A second element of the study was to evaluate the effectiveness of cleaning the 
treatment head with 70% alcohol which significantly reduced the level of 
contamination on transducer heads. The authors conclude that routine cleaning of 
the treatment head with 70% alcohol between treatments should be the clinical 
‘norm’, and although this does not deal with the micro-organism colonies in the gel 
bottles sampled, it is at least a significant move in the right direction, and is currently 
being advocated as best practice. 
 
Re-usable gel containers are likely to be a bigger problem in this regard, and if large 
volume gel containers are purchased (for gains in cost saving), it is unlikely to be 
good practice to keep refilling the same small bottles for use in the department. At 
the very least, either new or sterilised clean bottles should be used to reduce the risk 
until further research and management strategies have been identified. 
 
Dose Issues 
 
The widely used term ‘treatment dose’ of an ultrasound application is used in the 
clinical environment as a combination of the selectable machine parameters – 
frequency, power density, duty cycle and treatment time, thus has a more casual 
meaning than in the classic physics sense. 
 
Whilst it is beyond the scope of this review to consider dosing issues in detail, there 
are several general points that merit brief consideration. Firstly, there does appear to 
be a dose dependency in relation to therapeutic effects [5], though as identified 
previously, this has been challenged in the literature [61]. There are a myriad of 
possible combinations of frequency, power, power density, duty cycle and treatment 
times and from the published evidence it appears that there are some combinations 
that are more effective than others. There is not an exhaustive range of clinical 
literature from which to make absolutely definitive suggestions, but the trends that 
have emerged are sufficiently strong to justify a dose decision making model that is 
effective and amenable to adjustment as new research comes to light [67]. 
 
Given the growing evidence for therapeutic windows in most, if not all areas of 
practice, the main concern is to try and identify which of the dose parameters that 
can be manipulated are in fact the most critical and which are less important. 
Leaving to one side the general decision with regards ultrasound frequency, the 
power density (W cm-2), duty cycle and total treatment time appear to be 
fundamental. Although there is a trend for outcomes to be related to the actually duty 
cycle (20%, 25%, 33% etc), the more basic decision is whether to apply the energy 
in a continuous or pulsed mode. The continuous mode will result in more rapid 
delivery of the desired energy, but there is a strong, and growing body of evidence 
that support the contention that pulsed mode ultrasound is more effective than 
continuous mode, especially in relation to tissue repair, and most critically, in the 
early (inflammatory and proliferative) stages. 
 
An additional issue relates to current clinical practice and treatment frequency. Much 
of the research that has demonstrated significant clinical benefit has employed 
treatments at regular and relatively frequent intervals. Due to real world restrictions 
in current healthcare practice, many patients are seen regularly but infrequently (for 
example once every 2 or 4 weeks). If ultrasound is used when the patient attends on 
this basis, there is no evidence that there is a clinically significant gain – there may 
be, but this is a case of a lack of evidence as opposed to evidence of a lack of effect 
– an area needing some urgent consideration. 
 
Further evaluation of effective doses is being undertaken in this research unit, and it 
is anticipated that a more comprehensive dose model will emerge as a result. 
 
 
Overlap between Modalities 
 
At face value, the therapeutic effects of ultrasound are remarkably similar to those of 
laser therapy and some pulsed EM fields. Given that all three are means of 
delivering energy such that cellular up-regulation results, this is actually not 
surprising. The fundamental difference relates back not to a difference in their basic 
effect, but more strongly to the fact that these three energies are preferentially 
absorbed in different tissues [19]. There do appear to be some variations between 
the physiological effects of these interventions, but for the most part, they appear to 
overlap. Ultrasound is most effective at achieving these effects in the tissues that 
absorb then mechanical energy, and as described above, these are essentially the 
dense collagenous tissues. The modality is less effective when it comes to dealing 
with therapeutic gains in tissues like muscle, nerve and where there is significant 
oedema. The other modalities appear to offer advantages in these other tissues, and 
hence, the use of laser, pulsed EM fields (mainly shortwave) and ultrasound are 
regarded as being complementary rather than competitive in clinical practice. 
 
Summary 
 
Therapeutic ultrasound has a long history of use in physiotherapy practice, though 
the emphasis has changed over the last 15-20 years. Several other professional 
groups are also using the modality including osteopaths, chiropractors, podiatrists 
and sports therapists. The current emphasis of use relates to enhancement of repair 
of soft (musculoskeletal) tissues following injury, insult or irritation, and the evidence 
for its value in these areas is considerable, though there are, of course, gaps that 
remain and need to be filled with quality research especially in the clinical arena as 
opposed to the laboratory. 
 
  
Figures 
 
Figure 1 : Ultrasound tissue absorption characteristics 
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Figure 2 : Thermographic images of the hand before and after ultrasound 
 
(a) Baseline thermograph 
 
 
(b) Thermograph at the end of the 5 minute treatment period 
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